Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
This cuts total time to 6 months versus the standard 9 months
Eli Lilly is expected to file for FDA approval in 2026 following TRIUMPH-1 results
In adults with obesity and knee osteoarthritis, retatrutide delivered: 9mg dose: 26.4% body weight reduction at 68 weeks 12mg dose: 28.7% body weight reduction at 68 weeks (average of 71.2 pounds lost) Placebo: 2.1% body weight reduction The 68-week timeframe is longer than the Phase 2 trial, which partially explains the higher numbers
Food Sci Nutr, 12: 9607-9620
Energy expenditure declines
US$ 23.74
US$ 27.98
US$ 28.43
US$ 20.23
US$ 21.73
US$ 23.83
